BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35710379)

  • 1. Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis.
    Zhang Z; Miao L; Wang S; Zhao Y; Xie Y; Yun H; Ren Z; Wang G; Teng M; Li Y
    World J Surg Oncol; 2022 Jun; 20(1):204. PubMed ID: 35710379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
    Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
    BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
    Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total iron-binding capacity is a novel prognostic marker after curative gastrectomy for gastric cancer.
    Sawayama H; Iwatsuki M; Kuroda D; Toihata T; Uchihara T; Koga Y; Yagi T; Kiyozumi Y; Eto T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Baba H
    Int J Clin Oncol; 2018 Aug; 23(4):671-680. PubMed ID: 29633053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
    Tong Y; Zhao Y; Shan Z; Zhang J
    BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
    Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
    BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer.
    Wang X; Jia R; Chen K; Wang J; Jiang K; Wang Z
    Technol Cancer Res Treat; 2021; 20():15330338211039670. PubMed ID: 34931925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.
    Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Reim D; Choi YS; Yoon HM; Park B; Eom BW; Kook MC; Ryu KW; Choi IJ; Joo J; Kim YW
    Eur J Surg Oncol; 2017 Aug; 43(8):1542-1549. PubMed ID: 28511775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinicopathologic characteristics of gastric cancer patients undergoing gastrectomy based on a single-center gastric cancer database with above 10 000 cases].
    Liang WQ; Xi HQ; Qiao S; Cui JX; Zhang KC; Gao YH; Song YN; Zhang L; Luo H; Wei B; Xue WG; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1051-1058. PubMed ID: 33212553
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.
    Song XH; Zhang WH; Kai-Liu ; Chen XL; Zhao LY; Chen XZ; Kun-Yang ; Zhou ZG; Hu JK
    World J Surg Oncol; 2020 Aug; 18(1):204. PubMed ID: 32792016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
    Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
    Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.